New to The Street will continue its coverage with a powerful combination of national TV commercials, long-form interviews, earned media placements, and exposure on iconic outdoor billboards NEW YORK ...

Notable research news last week included US biopharma Avidity Biosciences announcing a positive update on its muscular ...

NEW YORK CITY, NEW YORK / ACCESS Newswire / June 14, 2025 / New to The Street (NTTS) and High Performance Battery Technology ...

TAMPA, FL / ACCESS Newswire / June 13, 2025 / NeuroEM Therapeutics®, an award-winning clinical-stage biotechnology research ...

In other developments, the ECDC today reported a slow rise in COVID activity in the Europe, which may partly reflect waning ...

The FDA approved mResvia for the prevention of RSV in people ages 18 to 59 years who are at increased risk for severe disease ...

The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include ...

RESVIA is now authorized for use in adults aged 18–59 years with an increased risk of respiratory syncytial virus-related ...

The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the ...

PIONEERTOWN, CA / ACCESS Newswire / June 13, 2025 / ESCAPE Records releases two transcendent works from its secretive Mojave ...

The agency’s decision to clear Moderna’s shot for use in certain younger adults is a much-needed win for a company that’s ...

US mRNA specialist Moderna today announced that the US Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345), ...